With regard to women with pathogenic variants in BRCA1/2 genes, in contrast, none of the studies examining the effect of HRT on BC and OC risk in this subgroup reported a significant effect of HRT, probably due to the smaller case numbers included. The gene discussed is BRCA1; the disease is breast cancer.